Completed Cells, Biochemistry & Physiology Heart, Stroke & Blood

Redox-regulated adaptive pathways in heart failure (renewal)

In plain English

AI plain-English summary

A chemical that damages heart muscle in one form may protect it in another—and researchers are now working out how to harness the protective version for treatment. Heart failure occurs when the heart cannot pump enough blood, often because chronic high blood pressure or other stresses have thickened and scarred the heart muscle. For years, scientists believed that all reactive oxygen species—highly reactive chemicals that can damage cells—were harmful in heart failure. But this team discovered that one particular enzyme, NOX4, actually helps the heart adapt to stress by triggering several protective pathways: it boosts blood vessel growth, activates cellular defence systems, and reprograms how heart cells use energy. Meanwhile, a related enzyme, NOX2, does the opposite—it drives the damage that leads to heart failure. If the researchers can work out exactly how NOX4 triggers these beneficial effects, they may identify new drug targets that mimic its protective actions without blocking the harmful NOX2. This could lead to treatments that help the heart cope with chronic stress, potentially slowing or preventing the progression of heart failure. The work also explains why previous attempts to treat heart failure with general antioxidants failed—they wiped out both the harmful and the helpful reactive oxygen species.

View original technical description
Reactive oxygen species (ROS)-generating NADPH oxidases (NOXs) regulate redox signalling in the heart under chronic overload stress. We and others previously showed that NOX2 promotes heart failure by enhancing hypertrophy, contractile dysfunction, fibrosis and cell death. NOX2 inhibition is thus currently a promising therapeutic target. More recently, we unexpectedly found that the other main cardiac NOX isoform, NOX4, has beneficial effects in the chronically overloaded heart. We found that NOX4 specifically regulates several potentially adaptive pathways: (a) HIF1-mediated angiogenesis, (b) NRF2-mediated cytoprotection, (c) an ATF4-mediated integrated stress response pathway, and (d) a novel cellular metabolic reprogramming. These newly-identified interacting pathways may provide tractable therapeutic targets in heart failure, as well as explaining why untargeted antioxidant approaches have been unsuccessful in clinical trials. This programme will define the roles, underlying mechanisms and therapeutic potential of NRF2- and ATF4-mediated pathways and of NOX4-dependent metabolic reprogramming in cardiac adaptation to chronic overload stress.

View the original record at the funder ↗

Researchers

Ajay Shah (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

NADPH oxidase-2 activation as a pathogenic mechanism and potential therapeutic target in heart failure with preserved ejection fraction
Regulation of cariomyocyte cell cycling by nuclear NOX4D
Defining key mechanisms underlying NOX4 signalling in endothelial colony-forming cells towards improved vasoreparative capacity in ischaemic disease
The role of Nrf2 (nuclear factor erythroid 2 related factor 2) in the cardiac response to chronic overload stress.
Role of peroxisome proliferator-activated receptor-alpha and NADPH oxidases in hypertensive cardiac remodeling

Original classification

Programme Grant

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.